Stock Earnings

Question 1

Mirum Pharmaceuticals Inc 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Mirum Pharmaceuticals Inc 的总资产为 $670，净loss为 $-87

Question 2

MIRM 的关键财务比率是什么？

Accepted Answer

Mirum Pharmaceuticals Inc 的流动比率是 1.5，净利 margin 为 -25.89，每股销售为 $7.07。

Question 3

Mirum Pharmaceuticals Inc 的收入按细分市场或地理位置如何划分？

Accepted Answer

Mirum Pharmaceuticals Inc largest revenue segment is Pharmaceutical, at a revenue of 336,409,000 in the most earnings release.For geography, United States is the primary market for Mirum Pharmaceuticals Inc, at a revenue of 274,173,000.

Question 4

Mirum Pharmaceuticals Inc 是否盈利？

Accepted Answer

no，根据最新的财务报表，Mirum Pharmaceuticals Inc 的净loss为 $-87

Question 5

Mirum Pharmaceuticals Inc 有负债吗？

Accepted Answer

yes，Mirum Pharmaceuticals Inc 的负债为 445

Question 6

Mirum Pharmaceuticals Inc 的流通股有多少？

Accepted Answer

Mirum Pharmaceuticals Inc 的总流通股为 48.33

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	429	336	186	77	19	0
Revenue Growth (YoY)	63%	81%	142%	305%	--	--
Cost of Revenue	90	81	47	12	1	--
Gross Profit	339	255	139	64	17	--
Selling, General & Admin	228	202	145	89	59	22
Research & Development	167	140	102	106	131	81
Operating Expenses	396	342	248	195	190	104
Other Non Operating Income (Expenses)	1	1	-2	0	0	0
Pretax Income	-57	-86	-162	-142	-83	-103
Income Tax Expense	1	1	0	-6	0	0
Net Income	-58	-87	-163	-135	-83	-103
Net Income Growth	-47%	-47%	21%	63%	-19%	98%
Shares Outstanding (Diluted)	49.72	47.52	40.88	33.84	30.32	25.25
Shares Change (YoY)	5%	16%	21%	12%	20%	10%
EPS (Diluted)	-1.17	-1.85	-3.99	-4.01	-2.77	-4.09
EPS Growth	-49%	-54%	0%	45%	-32%	79%
Free Cash Flow	-1	-10	-91	-120	-151	-89
Free Cash Flow Per Share	-0.02	-0.21	-2.22	-3.54	-4.98	-3.52
Gross Margin	79.02%	75.89%	74.73%	83.11%	89.47%	--
Operating Margin	-13.28%	-25.89%	-58.6%	-170.12%	-910.52%	0%
Profit Margin	-13.51%	-25.89%	-87.63%	-175.32%	-436.84%	0%
Free Cash Flow Margin	-0.23%	-2.97%	-48.92%	-155.84%	-794.73%	0%
EBITDA	-33	-64	-99	-128	-173	-104
EBITDA Margin	-7.69%	-19.04%	-53.22%	-166.23%	-910.52%	0%
D&A For EBITDA	24	23	10	3	0	0
EBIT	-57	-87	-109	-131	-173	-104
EBIT Margin	-13.28%	-25.89%	-58.6%	-170.12%	-910.52%	0%
Effective Tax Rate	-1.75%	-1.16%	0%	4.22%	0%	0%

Mirum Pharmaceuticals Inc (MIRM) Price

MIRM Stock Price Chart

MIRM Income

Follow-Up Questions